Market Cap 49.93M
Revenue (ttm) 0.00
Net Income (ttm) -111.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,131,500
Avg Vol 3,506,026
Day's Range N/A - N/A
Shares Out 87.58M
Stochastic %K 2%
Beta 2.83
Analysts Strong Sell
Price Target $10.14

Latest News on TNYA

Tenaya Therapeutics Announces Pricing of Public Offering

Mar 3, 2025, 11:19 PM EST - 4 weeks ago

Tenaya Therapeutics Announces Pricing of Public Offering


Tenaya Therapeutics Announces Proposed Public Offering

Mar 3, 2025, 4:10 PM EST - 4 weeks ago

Tenaya Therapeutics Announces Proposed Public Offering


Tenaya Therapeutics Announces Research Leadership Updates

Jun 27, 2024, 5:00 PM EDT - 10 months ago

Tenaya Therapeutics Announces Research Leadership Updates


Tenaya Therapeutics Announces Closing of Public Offering

Nov 21, 2022, 5:45 PM EST - 2 years ago

Tenaya Therapeutics Announces Closing of Public Offering